Candel Therapeutics News - CADL

Company Name	Stock Ticker Symbol	Market	Type
Candel Therapeutics Inc	CADL	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.08	-1.24%	6.35	14:02:11

Open Price	Low Price	High Price	Close Price	Prev Close
6.60	6.02	6.60		6.43

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	08:00	GLOBE	Candel Therapeutics Announces Upcoming Presentations at the..
4/11/2024	09:00	GLOBE	Candel Therapeutics Receives FDA Orphan Drug Designation for..
4/09/2024	08:00	GLOBE	Candel Therapeutics Presents Preclinical Data at AACR on..
4/04/2024	08:00	GLOBE	Candel Therapeutics Announces Positive Interim Data from..
3/28/2024	16:05	GLOBE	Candel Therapeutics Announces Oral Presentation During the..
3/28/2024	08:05	GLOBE	Candel Therapeutics Reports Fourth Quarter and Full Year..
3/06/2024	08:00	EDGAR2	Form 8-K - Current report
3/05/2024	16:30	GLOBE	Candel Therapeutics Announces an Upcoming Presentation at..
2/13/2024	09:00	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/13/2024	07:45	EDGAR2	Form 8-K - Current report
2/13/2024	07:30	GLOBE	CAN-3110 Receives FDA Fast Track Designation for Treatment..
2/05/2024	08:00	GLOBE	Candel Therapeutics Sets Path to Success: Recent..
1/19/2024	08:30	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
1/12/2024	16:30	EDGAR2	Form 8-K - Current report
1/03/2024	08:30	EDGAR2	Form 8-K - Current report
12/12/2023	08:58	DJN	Candel Therapeutics Shares Soar After FDA Fast Track of..
12/12/2023	08:30	EDGAR2	Form 8-K - Current report
12/12/2023	08:00	GLOBE	Candel Therapeutics Receives FDA Fast Track Designation for..
11/30/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/30/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/30/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/28/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/28/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/28/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/28/2023	09:00	EDGAR2	Form 8-K - Current report
11/28/2023	09:00	GLOBE	Candel Therapeutics Announces Restructuring to Prioritize..
11/21/2023	17:00	EDGAR2	Form 8-K - Current report
11/09/2023	08:31	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	08:16	EDGAR2	Form 8-K - Current report
11/09/2023	08:00	GLOBE	Candel Therapeutics Reports Third Quarter 2023 Financial..
11/06/2023	08:53	EDGAR2	Form 8-K - Current report
11/06/2023	08:15	EDGAR2	Form 8-K - Current report
11/04/2023	08:00	GLOBE	Candel Therapeutics Presents Preclinical Data from its..
11/03/2023	12:00	GLOBE	Candel Therapeutics Announces Initial Positive Interim Data..
10/18/2023	11:31	EDGAR2	Form 8-K - Current report
10/18/2023	11:00	GLOBE	Candel Therapeutics Announces Nature Publication Showing..
9/27/2023	09:40	GLOBE	Candel Therapeutics Announces Three Abstracts Accepted for..
9/26/2023	08:30	EDGAR2	Form 8-K - Current report
9/26/2023	08:00	GLOBE	Candel Therapeutics Reports Encouraging Initial Survival..
9/06/2023	08:00	GLOBE	Candel Therapeutics to Participate in the H.C. Wainwright..
8/10/2023	08:31	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	08:15	EDGAR2	Form 8-K - Current report
8/10/2023	08:00	GLOBE	Candel Therapeutics Reports Second Quarter 2023 Financial..
8/02/2023	08:00	GLOBE	Candel Therapeutics to Participate in the Canaccord Genuity..
6/29/2023	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/29/2023	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/29/2023	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/29/2023	08:31	EDGAR2	Form 8-K - Current report
6/13/2023	08:00	GLOBE	Candel Therapeutics Announces It Expects to Report Topline..
6/08/2023	08:00	GLOBE	Candel Therapeutics Appoints Experienced Manufacturing..